Aurinia Pharmaceuticals Inc.
AUPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600620
In the last 90 days, Aurinia Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 282 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Aurinia Pharmaceuticals Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 170 | 167 | −3 |
| Shares | 52.6M | 49.4M | −3.15M (−6.0%) |
| Value | $682.5M | $640.9M | −$41.7M (−6.1%) |
New holders (30)
Institutions that held Aurinia Pharmaceuticals Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (33)
Institutions that held Aurinia Pharmaceuticals Inc. at the end of Q1 2021 and filed for Q2 2021 without it.